Michael Skynner
CTO at Bicycle Therapeutics PLC (BCYC); Chief Scientific Officer at Bicycle Therapeutics PLC (BCYC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $88K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 1,942155,229 held (−1%) | $3.47 | $7K | +12.1% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 503154,726 held (−0%) | $3.57 | $2K | +9.0% |
| Jul 7SEC | BCYCBicycle Therapeutics PLC | Sell | 1,859157,703 held (−1%) | $4.27 | $8K | -8.9% |
| Jul 7SEC | BCYCBicycle Therapeutics PLC | Sell | 532157,171 held (−0%) | $4.31 | $2K | -9.7% |
| Apr 6SEC | BCYCBicycle Therapeutics PLC | Sell | 1,879160,087 held (−1%) | $4.91 | $9K | -20.8% |
| Apr 6SEC | BCYCBicycle Therapeutics PLC | Sell | 525159,562 held (−0%) | $5.05 | $3K | -23.0% |
| Jan 6SEC | BCYCBicycle Therapeutics PLC | Sell | 3,045165,232 held (−2%) | $6.80 | $21K | -42.8% |
| Jan 6SEC | BCYCBicycle Therapeutics PLC | Sell | 3,266161,966 held (−2%) | $6.46 | $21K | -39.8% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 824119,255 held (−1%) | $8.40 | $7K | -53.7% |
| Oct 6SEC | BCYCBicycle Therapeutics PLC | Sell | 978118,277 held (−1%) | $8.41 | $8K | -53.7% |